Global Non-Drug-Eluting Devices Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Non-Drug-Eluting Devices market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Non-Drug-Eluting Devices include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-Drug-Eluting Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Non-Drug-Eluting Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Non-Drug-Eluting Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Drug-Eluting Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Non-Drug-Eluting Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Non-Drug-Eluting Devices sales, projected growth trends, production technology, application and end-user industry.

Non-Drug-Eluting Devices Segment by Company

Teleflex Incorporated
Johnson & Johnson
Medtronic
Boston Scientific Corporation
B. Braun Melsungen AG
Stryker Corporation
Smith & Nephew plc.
Peter Surgical
Integra Lifesciences
DemeTECH Corporation
ConMed Corporation
Non-Drug-Eluting Devices Segment by Type

Implants
Sutures
Non-Drug-Eluting Devices Segment by Application

Hospital
Ambulatory Surgical Centers
Non-Drug-Eluting Devices Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Non-Drug-Eluting Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Drug-Eluting Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Non-Drug-Eluting Devices Market by Type
1.2.1 Global Non-Drug-Eluting Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Implants
1.2.3 Sutures
1.3 Non-Drug-Eluting Devices Market by Application
1.3.1 Global Non-Drug-Eluting Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Non-Drug-Eluting Devices Market Dynamics
2.1 Non-Drug-Eluting Devices Industry Trends
2.2 Non-Drug-Eluting Devices Industry Drivers
2.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
2.4 Non-Drug-Eluting Devices Industry Restraints
3 Global Market Growth Prospects
3.1 Global Non-Drug-Eluting Devices Revenue Estimates and Forecasts (2020-2031)
3.2 Global Non-Drug-Eluting Devices Revenue by Region
3.2.1 Global Non-Drug-Eluting Devices Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Non-Drug-Eluting Devices Revenue by Region (2020-2025)
3.2.3 Global Non-Drug-Eluting Devices Revenue by Region (2026-2031)
3.2.4 Global Non-Drug-Eluting Devices Revenue Market Share by Region (2020-2031)
3.3 Global Non-Drug-Eluting Devices Sales Estimates and Forecasts 2020-2031
3.4 Global Non-Drug-Eluting Devices Sales by Region
3.4.1 Global Non-Drug-Eluting Devices Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Non-Drug-Eluting Devices Sales by Region (2020-2025)
3.4.3 Global Non-Drug-Eluting Devices Sales by Region (2026-2031)
3.4.4 Global Non-Drug-Eluting Devices Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Non-Drug-Eluting Devices Revenue by Manufacturers
4.1.1 Global Non-Drug-Eluting Devices Revenue by Manufacturers (2020-2025)
4.1.2 Global Non-Drug-Eluting Devices Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Non-Drug-Eluting Devices Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Non-Drug-Eluting Devices Sales by Manufacturers
4.2.1 Global Non-Drug-Eluting Devices Sales by Manufacturers (2020-2025)
4.2.2 Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Non-Drug-Eluting Devices Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Non-Drug-Eluting Devices Sales Price by Manufacturers (2020-2025)
4.4 Global Non-Drug-Eluting Devices Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Non-Drug-Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Non-Drug-Eluting Devices Manufacturers, Product Type & Application
4.7 Global Non-Drug-Eluting Devices Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Non-Drug-Eluting Devices Market CR5 and HHI
4.8.2 2024 Non-Drug-Eluting Devices Tier 1, Tier 2, and Tier 3
5 Non-Drug-Eluting Devices Market by Type
5.1 Global Non-Drug-Eluting Devices Revenue by Type
5.1.1 Global Non-Drug-Eluting Devices Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Non-Drug-Eluting Devices Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Non-Drug-Eluting Devices Revenue Market Share by Type (2020-2031)
5.2 Global Non-Drug-Eluting Devices Sales by Type
5.2.1 Global Non-Drug-Eluting Devices Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Non-Drug-Eluting Devices Sales by Type (2020-2031) & (K Units)
5.2.3 Global Non-Drug-Eluting Devices Sales Market Share by Type (2020-2031)
5.3 Global Non-Drug-Eluting Devices Price by Type
6 Non-Drug-Eluting Devices Market by Application
6.1 Global Non-Drug-Eluting Devices Revenue by Application
6.1.1 Global Non-Drug-Eluting Devices Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Non-Drug-Eluting Devices Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Non-Drug-Eluting Devices Revenue Market Share by Application (2020-2031)
6.2 Global Non-Drug-Eluting Devices Sales by Application
6.2.1 Global Non-Drug-Eluting Devices Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Non-Drug-Eluting Devices Sales by Application (2020-2031) & (K Units)
6.2.3 Global Non-Drug-Eluting Devices Sales Market Share by Application (2020-2031)
6.3 Global Non-Drug-Eluting Devices Price by Application
7 Company Profiles
7.1 Teleflex Incorporated
7.1.1 Teleflex Incorporated Comapny Information
7.1.2 Teleflex Incorporated Business Overview
7.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
7.1.5 Teleflex Incorporated Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Comapny Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
7.2.5 Johnson & Johnson Recent Developments
7.3 Medtronic
7.3.1 Medtronic Comapny Information
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
7.3.5 Medtronic Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Comapny Information
7.4.2 Boston Scientific Corporation Business Overview
7.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
7.4.5 Boston Scientific Corporation Recent Developments
7.5 B. Braun Melsungen AG
7.5.1 B. Braun Melsungen AG Comapny Information
7.5.2 B. Braun Melsungen AG Business Overview
7.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
7.5.5 B. Braun Melsungen AG Recent Developments
7.6 Stryker Corporation
7.6.1 Stryker Corporation Comapny Information
7.6.2 Stryker Corporation Business Overview
7.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
7.6.5 Stryker Corporation Recent Developments
7.7 Smith & Nephew plc.
7.7.1 Smith & Nephew plc. Comapny Information
7.7.2 Smith & Nephew plc. Business Overview
7.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
7.7.5 Smith & Nephew plc. Recent Developments
7.8 Peter Surgical
7.8.1 Peter Surgical Comapny Information
7.8.2 Peter Surgical Business Overview
7.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
7.8.5 Peter Surgical Recent Developments
7.9 Integra Lifesciences
7.9.1 Integra Lifesciences Comapny Information
7.9.2 Integra Lifesciences Business Overview
7.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
7.9.5 Integra Lifesciences Recent Developments
7.10 DemeTECH Corporation
7.10.1 DemeTECH Corporation Comapny Information
7.10.2 DemeTECH Corporation Business Overview
7.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
7.10.5 DemeTECH Corporation Recent Developments
7.11 ConMed Corporation
7.11.1 ConMed Corporation Comapny Information
7.11.2 ConMed Corporation Business Overview
7.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
7.11.5 ConMed Corporation Recent Developments
8 North America
8.1 North America Non-Drug-Eluting Devices Market Size by Type
8.1.1 North America Non-Drug-Eluting Devices Revenue by Type (2020-2031)
8.1.2 North America Non-Drug-Eluting Devices Sales by Type (2020-2031)
8.1.3 North America Non-Drug-Eluting Devices Price by Type (2020-2031)
8.2 North America Non-Drug-Eluting Devices Market Size by Application
8.2.1 North America Non-Drug-Eluting Devices Revenue by Application (2020-2031)
8.2.2 North America Non-Drug-Eluting Devices Sales by Application (2020-2031)
8.2.3 North America Non-Drug-Eluting Devices Price by Application (2020-2031)
8.3 North America Non-Drug-Eluting Devices Market Size by Country
8.3.1 North America Non-Drug-Eluting Devices Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Non-Drug-Eluting Devices Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Non-Drug-Eluting Devices Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Non-Drug-Eluting Devices Market Size by Type
9.1.1 Europe Non-Drug-Eluting Devices Revenue by Type (2020-2031)
9.1.2 Europe Non-Drug-Eluting Devices Sales by Type (2020-2031)
9.1.3 Europe Non-Drug-Eluting Devices Price by Type (2020-2031)
9.2 Europe Non-Drug-Eluting Devices Market Size by Application
9.2.1 Europe Non-Drug-Eluting Devices Revenue by Application (2020-2031)
9.2.2 Europe Non-Drug-Eluting Devices Sales by Application (2020-2031)
9.2.3 Europe Non-Drug-Eluting Devices Price by Application (2020-2031)
9.3 Europe Non-Drug-Eluting Devices Market Size by Country
9.3.1 Europe Non-Drug-Eluting Devices Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Non-Drug-Eluting Devices Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Non-Drug-Eluting Devices Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Non-Drug-Eluting Devices Market Size by Type
10.1.1 China Non-Drug-Eluting Devices Revenue by Type (2020-2031)
10.1.2 China Non-Drug-Eluting Devices Sales by Type (2020-2031)
10.1.3 China Non-Drug-Eluting Devices Price by Type (2020-2031)
10.2 China Non-Drug-Eluting Devices Market Size by Application
10.2.1 China Non-Drug-Eluting Devices Revenue by Application (2020-2031)
10.2.2 China Non-Drug-Eluting Devices Sales by Application (2020-2031)
10.2.3 China Non-Drug-Eluting Devices Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Non-Drug-Eluting Devices Market Size by Type
11.1.1 Asia Non-Drug-Eluting Devices Revenue by Type (2020-2031)
11.1.2 Asia Non-Drug-Eluting Devices Sales by Type (2020-2031)
11.1.3 Asia Non-Drug-Eluting Devices Price by Type (2020-2031)
11.2 Asia Non-Drug-Eluting Devices Market Size by Application
11.2.1 Asia Non-Drug-Eluting Devices Revenue by Application (2020-2031)
11.2.2 Asia Non-Drug-Eluting Devices Sales by Application (2020-2031)
11.2.3 Asia Non-Drug-Eluting Devices Price by Application (2020-2031)
11.3 Asia Non-Drug-Eluting Devices Market Size by Country
11.3.1 Asia Non-Drug-Eluting Devices Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Non-Drug-Eluting Devices Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Non-Drug-Eluting Devices Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Non-Drug-Eluting Devices Market Size by Type
12.1.1 SAMEA Non-Drug-Eluting Devices Revenue by Type (2020-2031)
12.1.2 SAMEA Non-Drug-Eluting Devices Sales by Type (2020-2031)
12.1.3 SAMEA Non-Drug-Eluting Devices Price by Type (2020-2031)
12.2 SAMEA Non-Drug-Eluting Devices Market Size by Application
12.2.1 SAMEA Non-Drug-Eluting Devices Revenue by Application (2020-2031)
12.2.2 SAMEA Non-Drug-Eluting Devices Sales by Application (2020-2031)
12.2.3 SAMEA Non-Drug-Eluting Devices Price by Application (2020-2031)
12.3 SAMEA Non-Drug-Eluting Devices Market Size by Country
12.3.1 SAMEA Non-Drug-Eluting Devices Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Non-Drug-Eluting Devices Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Non-Drug-Eluting Devices Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Non-Drug-Eluting Devices Value Chain Analysis
13.1.1 Non-Drug-Eluting Devices Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Non-Drug-Eluting Devices Production Mode & Process
13.2 Non-Drug-Eluting Devices Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Non-Drug-Eluting Devices Distributors
13.2.3 Non-Drug-Eluting Devices Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings